1
|
Maruf A, Milewska M, Varga M, Wandzik I. Trehalose-Bearing Carriers to Target Impaired Autophagy and Protein Aggregation Diseases. J Med Chem 2023; 66:15613-15628. [PMID: 38031413 PMCID: PMC10726369 DOI: 10.1021/acs.jmedchem.3c01442] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2023] [Revised: 11/02/2023] [Accepted: 11/15/2023] [Indexed: 12/01/2023]
Abstract
In recent years, trehalose, a natural disaccharide, has attracted growing attention because of the discovery of its potential to induce autophagy. Trehalose has also been demonstrated to preserve the protein's structural integrity and to limit the aggregation of pathologically misfolded proteins. Both of these properties have made trehalose a promising therapeutic candidate to target autophagy-related disorders and protein aggregation diseases. Unfortunately, trehalose has poor bioavailability due to its hydrophilic nature and susceptibility to enzymatic degradation. Recently, trehalose-bearing carriers, in which trehalose is incorporated either by chemical conjugation or physical entrapment, have emerged as an alternative option to free trehalose to improve its efficacy, particularly for the treatment of neurodegenerative diseases, atherosclerosis, nonalcoholic fatty liver disease (NAFLD), and cancers. In the current Perspective, we discuss all existing literature in this emerging field and try to identify key challenges for researchers intending to develop trehalose-bearing carriers to stimulate autophagy or inhibit protein aggregation.
Collapse
Affiliation(s)
- Ali Maruf
- Department
of Organic Chemistry, Bioorganic Chemistry and Biotechnology, Faculty
of Chemistry, Silesian University of Technology, Krzywoustego 4, 44-100 Gliwice, Poland
- Biotechnology
Center, Silesian University of Technology, Krzywoustego 8, 44-100 Gliwice, Poland
- Drug
Research Progam, Faculty of Pharmacy, University
of Helsinki, Viikinkaari
5E, 00014 Helsinki, Finland
| | - Małgorzata Milewska
- Department
of Organic Chemistry, Bioorganic Chemistry and Biotechnology, Faculty
of Chemistry, Silesian University of Technology, Krzywoustego 4, 44-100 Gliwice, Poland
- Biotechnology
Center, Silesian University of Technology, Krzywoustego 8, 44-100 Gliwice, Poland
| | - Máté Varga
- Department
of Genetics, ELTE Eötvös Loránd
University, Pázmány
P. stny. 1/C, Budapest H-1117, Hungary
| | - Ilona Wandzik
- Department
of Organic Chemistry, Bioorganic Chemistry and Biotechnology, Faculty
of Chemistry, Silesian University of Technology, Krzywoustego 4, 44-100 Gliwice, Poland
- Biotechnology
Center, Silesian University of Technology, Krzywoustego 8, 44-100 Gliwice, Poland
| |
Collapse
|
2
|
Colombo E, Aydın EM, Canıtez İS, Polito L, Penconi M, Bossi A, Impresari E, Passarella D, Dallavalle S, Athanassopoulos CM, Pellegrino S, Şahin ID, Christodoulou MS. Tetraphenylethylene-Based Photoluminescent Self-Assembled Nanoparticles: Preparation and Biological Evaluation. ACS Med Chem Lett 2023; 14:1472-1477. [PMID: 37849561 PMCID: PMC10577884 DOI: 10.1021/acsmedchemlett.3c00396] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2023] [Accepted: 09/26/2023] [Indexed: 10/19/2023] Open
Abstract
The conjugation of tetraphenylethylene (TPE) with podophyllotoxin, N-desacetylthiocolchicine, and cabazitaxel through a sebacic acid linker led to the formation of fluorescent nanoparticles. Dynamic light scattering (DLS) and photoluminescence spectroscopy were used for the identification and characterization of the fluorescent nanoparticles. The biological evaluation was determined in three human ovarian (KURAMOCHI, OVCAR3, OVSAHO) and three human breast (MCF7, SKBR 3, and MDA-MB231) cancer cell lines. In the case of cabazitaxel, the nanoparticles maintained the activity of the parent drug, at the low nanomolar range, while exhibiting high blue fluorescence. The internalization of the fluorescent NPs into cells was detected using immunofluorescence assay.
Collapse
Affiliation(s)
- Eleonora Colombo
- Dipartimento
di Chimica, Universitá degli Studi
di Milano, 20133 Milano, Italy
- Ann Romney
Center for Neurologic Diseases, Department of Neurology, Brigham and Women’s Hospital and Harvard Medical
School, Boston, Massachusetts 02115, United States
| | - Elif Merve Aydın
- Koc
University Research Center for Translational Medicine (KUTTAM), Sariyer, Istanbul 34450, Turkey
| | - İdil Su Canıtez
- Koc
University Research Center for Translational Medicine (KUTTAM), Sariyer, Istanbul 34450, Turkey
| | - Laura Polito
- Istituto
di Scienze e Tecnologie Chimiche “Giulio Natta”, SCITEC−CNR, 20138 Milano, Italy
| | - Marta Penconi
- Istituto
di Scienze e Tecnologie Chimiche “Giulio Natta”, SCITEC−CNR, 20138, Milano, Italy
- SmartMatLab
Center, 20133 Milano, Italy
| | - Alberto Bossi
- Istituto
di Scienze e Tecnologie Chimiche “Giulio Natta”, SCITEC−CNR, 20138, Milano, Italy
- SmartMatLab
Center, 20133 Milano, Italy
| | - Elisa Impresari
- DISFARM,
Dipartimento di Scienze Farmaceutiche, Sezione Chimica Generale e
Organica “A. Marchesini”, Università degli Studi di Milano, 20133 Milano, Italy
| | - Daniele Passarella
- Dipartimento
di Chimica, Universitá degli Studi
di Milano, 20133 Milano, Italy
| | - Sabrina Dallavalle
- Department
of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, via Celoria 2, 20133 Milan, Italy
| | | | - Sara Pellegrino
- DISFARM,
Dipartimento di Scienze Farmaceutiche, Sezione Chimica Generale e
Organica “A. Marchesini”, Università degli Studi di Milano, 20133 Milano, Italy
| | | | - Michael S. Christodoulou
- Department
of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, via Celoria 2, 20133 Milan, Italy
| |
Collapse
|
3
|
Antoniou AI, Nordio G, Di Paolo ML, Colombo E, Gaffuri B, Polito L, Amenta A, Seneci P, Dalla Via L, Perdicchia D, Passarella D. 2-Hydroxyoleic Acid as a Self-Assembly Inducer for Anti-Cancer Drug-Centered Nanoparticles. Pharmaceuticals (Basel) 2023; 16:ph16050722. [PMID: 37242505 DOI: 10.3390/ph16050722] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2023] [Revised: 05/02/2023] [Accepted: 05/06/2023] [Indexed: 05/28/2023] Open
Abstract
A potent nontoxic antitumor drug, 2-hydroxyoleic acid (6, 2OHOA) used for membrane lipid therapy, was selected as a self-assembly inducer due to its ability to form nanoparticles (NPs) in water. For this purpose, it was conjugated with a series of anticancer drugs through a disulfide-containing linker to enhance cell penetration and to secure drug release inside the cell. The antiproliferative evaluation of the synthesized NP formulations against three human tumor cell lines (biphasic mesothelioma MSTO-211H, colorectal adenocarcinoma HT-29, and glioblastoma LN-229) showed that nanoassemblies 16-22a,bNPs exhibit antiproliferative activity at micromolar and submicromolar concentrations. Furthermore, the ability of the disulfide-containing linker to promote cellular effects was confirmed for most nanoformulations. Finally, 17bNP induced intracellular ROS increase in glioblastoma LN-229 cells similarly to free drug 8, and such elevated production was decreased by pretreatment with the antioxidant N-acetylcysteine. Also, nanoformulations 18bNP and 21bNP confirmed the mechanism of action of the free drugs.
Collapse
Affiliation(s)
- Antonia I Antoniou
- Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy
| | - Giulia Nordio
- Dipartimento di Scienze del Farmaco, Università degli Studi di Padova, Via F. Marzolo 5, 35131 Padova, Italy
| | - Maria Luisa Di Paolo
- Dipartimento di Medicina Molecolare, Università degli Studi di Padova, Via G. Colombo 3, 35131 Padova, Italy
| | - Eleonora Colombo
- Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy
| | - Beatrice Gaffuri
- Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy
| | - Laura Polito
- Istituto di Scienze e Tecnologie Chimiche "Giulio Natta", SCITEC-CNR, Via G. Fantoli 16/15, 20138 Milano, Italy
| | - Arianna Amenta
- Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy
| | - Pierfausto Seneci
- Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy
| | - Lisa Dalla Via
- Dipartimento di Scienze del Farmaco, Università degli Studi di Padova, Via F. Marzolo 5, 35131 Padova, Italy
| | - Dario Perdicchia
- Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy
| | - Daniele Passarella
- Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy
| |
Collapse
|
4
|
Cannabidiol as Self-Assembly Inducer for Anticancer Drug-Based Nanoparticles. MOLECULES (BASEL, SWITZERLAND) 2022; 28:molecules28010112. [PMID: 36615306 PMCID: PMC9822096 DOI: 10.3390/molecules28010112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/10/2022] [Revised: 12/07/2022] [Accepted: 12/20/2022] [Indexed: 12/24/2022]
Abstract
Cannabidiol (CBD) is a biologically active compound present in the plants of the Cannabis family, used as anticonvulsant, anti-inflammatory, anti-anxiety, and more recently, anticancer drug. In this work, its use as a new self-assembly inducer in the formation of nanoparticles is validated. The target conjugates are characterized by the presence of different anticancer drugs (namely N-desacetyl thiocolchicine, podophyllotoxin, and paclitaxel) connected to CBD through a linker able to improve drug release. These nanoparticles are formed via solvent displacement method, resulting in monodisperse and stable structures having hydrodynamic diameters ranging from 160 to 400 nm. Their biological activity is evaluated on three human tumor cell lines (MSTO-211H, HT-29, and HepG2), obtaining GI50 values in the low micromolar range. Further biological assays were carried out on MSTO-211H cells for the most effective NP 8B, confirming the involvement of paclitaxel in cytotoxicity and cell death mechanism.
Collapse
|
5
|
Colombo E, Coppini DA, Maculan S, Seneci P, Santini B, Testa F, Salvioni L, Vanacore GM, Colombo M, Passarella D. Folic acid functionalization for targeting self-assembled paclitaxel-based nanoparticles. RSC Adv 2022; 12:35484-35493. [PMID: 36544466 PMCID: PMC9744106 DOI: 10.1039/d2ra06306a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2022] [Accepted: 12/06/2022] [Indexed: 12/14/2022] Open
Abstract
Hetero-nanoparticles self-assembled from a conjugate bearing folic acid as the targeting agent, and another bearing paclitaxel as the active agent are reported. Hetero-nanoparticles containing varying percentages of folic acid conjugates are characterised, and their biological activity is determined.
Collapse
Affiliation(s)
- Eleonora Colombo
- Dipartimento di Chimica, Università degli Studi di MilanoVia Golgi 1920133 MilanoItaly
| | - Davide Andrea Coppini
- Dipartimento di Chimica, Università degli Studi di MilanoVia Golgi 1920133 MilanoItaly
| | - Simone Maculan
- Dipartimento di Chimica, Università degli Studi di MilanoVia Golgi 1920133 MilanoItaly
| | - Pierfausto Seneci
- Dipartimento di Chimica, Università degli Studi di MilanoVia Golgi 1920133 MilanoItaly
| | - Benedetta Santini
- Dipartimento di Chimica, Università degli Studi di MilanoVia Golgi 1920133 MilanoItaly
| | - Filippo Testa
- Dipartimento di Biotecnologie e Bioscienze, Università degli Studi di Milano BicoccaPiazza della Scienza 220126 MilanoItaly
| | - Lucia Salvioni
- Dipartimento di Biotecnologie e Bioscienze, Università degli Studi di Milano BicoccaPiazza della Scienza 220126 MilanoItaly
| | - Giovanni Maria Vanacore
- Dipartimento di Scienza dei Materiali, Università degli Studi di Milano BicoccaVia Roberto Cozzi 5520125 MilanoItaly
| | - Miriam Colombo
- Dipartimento di Biotecnologie e Bioscienze, Università degli Studi di Milano BicoccaPiazza della Scienza 220126 MilanoItaly
| | - Daniele Passarella
- Dipartimento di Chimica, Università degli Studi di MilanoVia Golgi 1920133 MilanoItaly
| |
Collapse
|
6
|
Pupyshev AB, Klyushnik TP, Akopyan AA, Singh SK, Tikhonova MA. Disaccharide Trehalose in Experimental Therapies for Neurodegenerative Disorders: Molecular Targets and Translational Potential. Pharmacol Res 2022; 183:106373. [PMID: 35907433 DOI: 10.1016/j.phrs.2022.106373] [Citation(s) in RCA: 14] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/31/2022] [Revised: 07/23/2022] [Accepted: 07/26/2022] [Indexed: 10/16/2022]
Abstract
Induction of autophagy is a prospective approach to the treatment of neurodegeneration. In the recent decade, trehalose attracted special attention. It is an autophagy inducer with negligible adverse effects and is approved for use in humans according to FDA requirements. Trehalose has a therapeutic effect in various experimental models of diseases. This glucose disaccharide with a flexible α-1-1'-glycosidic bond has unique properties: induction of mTOR-independent autophagy (with kinase AMPK as the main target) and a chaperone-like effect on proteins imparting them natural spatial structure. Thus, it can reduce the accumulation of neurotoxic aberrant/misfolded proteins. Trehalose has an anti-inflammatory effect and inhibits detrimental oxidative stress partially owing to the enhancement of endogenous antioxidant defense represented by the Nrf2 protein. The disaccharide activates lysosome and autophagosome biogenesis pathways through the protein factors TFEB and FOXO1. Here we review various mechanisms of the neuroprotective action of trehalose and touch on the possibility of pleiotropic effects. Current knowledge about specific features of trehalose pharmacodynamics is discussed. The neuroprotective effects of trehalose in animal models of major neurodegenerative disorders such as Alzheimer's, Parkinson's, and Huntington's diseases are examined too. Attention is given to translational transition to clinical trials of this drug, especially oral and parenteral routes of administration. Besides, the possibility of enhancing the therapeutic benefit via a combination of mTOR-dependent and mTOR-independent autophagy inducers is analyzed. In general, trehalose appears to be a promising multitarget tool for the inhibition of experimental neurodegeneration and requires thorough investigation of its clinical capabilities.
Collapse
Affiliation(s)
- Alexander B Pupyshev
- Scientific Research Institute of Neurosciences and Medicine (SRINM); Timakova Str. 4, Novosibirsk 630117, Russia.
| | - Tatyana P Klyushnik
- Mental Health Research Center, Kashirskoye shosse 34, Moscow 115522, Russia.
| | - Anna A Akopyan
- Scientific Research Institute of Neurosciences and Medicine (SRINM); Timakova Str. 4, Novosibirsk 630117, Russia.
| | - Sandeep Kumar Singh
- Indian Scientific Education and Technology Foundation, Krishna Bhawan, 594 Kha/123, Shahinoor Colony, Nilmatha, Uttar Pradesh, Lucknow 226002, India.
| | - Maria A Tikhonova
- Scientific Research Institute of Neurosciences and Medicine (SRINM); Timakova Str. 4, Novosibirsk 630117, Russia.
| |
Collapse
|